PCYNOTCPharmaceutical PreparationsFiscal year ends June 30
PROCYON CORP
Financials through Q4 FY2024, quarter ended Jun 30, 2024Last filing: 10-K on Oct 25, 2024
$0.18−0.09 (-31.48%)
Close on Oct 19, 2026
- Market cap
- $1.51M
- P/E (TTM)
- –
- Dividend yield
- –
Procyon statistics
Financials through Jun 30, 2024, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | Procyon | Industry median |
|---|---|---|
| Market Cap | $1.50M | $166.30M |
| Enterprise Value | $1.18M | $88.19M |
| PS Ratio | 0.30 | 3.65 |
| PB Ratio | 0.66 | 2.03 |
| P/TBV Ratio | 0.66 | 2.29 |
Enterprise value
| Measure | Procyon | Industry median |
|---|---|---|
| EV / Sales | 0.24 | 2.51 |
Income (trailing twelve months)
| Measure | Procyon | Industry median |
|---|---|---|
| Revenue | $4.98M | $58.34M |
| Gross Profit | $3.89M | $105.94M |
| Operating Income | -$231.71K | -$21.40M |
| Pretax Income | -$171.28K | -$14.34M |
| Net Income | -$341.14K | -$22.46M |
| EBITDA | -$231.71K | -$16.91M |
| EPS (Diluted) | -$0.04 | -$0.83 |
Margins
| Measure | Procyon | Industry median |
|---|---|---|
| Gross Margin | 78.1% | 52.9% |
| Operating Margin | -4.65% | -44.0% |
| Pretax Margin | -3.44% | -13.3% |
| Profit Margin | -6.84% | -40.2% |
| EBITDA Margin | -4.65% | -30.2% |
| FCF Margin | -2.51% | -9.27% |
Returns
| Measure | Procyon | Industry median |
|---|---|---|
| Return on Equity (ROE) | -13.9% | -53.2% |
| Return on Assets (ROA) | -10.1% | -40.9% |
| Return on Invested Capital (ROIC) | -8.87% | -32.4% |
| Return on Capital Employed (ROCE) | -9.51% | -38.1% |
Growth
| Measure | Procyon | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 6.35% | 5.96% |
| Revenue Growth (3Y CAGR) | 1.84% | 2.25% |
| Revenue Growth (5Y CAGR) | 3.53% | 6.48% |
Balance sheet
| Measure | Procyon | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $326.14K | $61.43M |
| Net Cash (Debt) | $326.14K | $15.35M |
| Net Cash Per Share | $0.04 | $0.66 |
| Equity (Book Value) | $2.29M | $49.09M |
| Book Value Per Share | $0.28 | $1.37 |
| Tangible Book Value | $2.27M | $23.52M |
| Working Capital | $1.60M | $76.81M |
Financial position
| Measure | Procyon | Industry median |
|---|---|---|
| Current Ratio | 3.08 | 3.34 |
| Quick Ratio | 1.09 | 2.44 |
Cash flow (trailing twelve months)
| Measure | Procyon | Industry median |
|---|---|---|
| Operating Cash Flow | -$61.25K | -$12.35M |
| Capital Expenditures | -$63.91K | -$1.08M |
| Free Cash Flow | -$125.16K | -$20.22M |
| FCF Per Share | -$0.02 | -$0.42 |
Efficiency
| Measure | Procyon | Industry median |
|---|---|---|
| Asset Turnover | 1.47 | 0.39 |
| Inventory Turnover | 2.32 | 2.70 |
| Revenue Per Employee | $262.34K | $404.87K |
| Profits Per Employee | -$17.95K | -$703.34K |
| Employee Count | 19 | 74 |
Dividends and yields
| Measure | Procyon | Industry median |
|---|---|---|
| Earnings Yield | -22.7% | -23.3% |
| FCF Yield | -8.33% | -8.72% |
Shares
| Measure | Procyon | Industry median |
|---|---|---|
| Shares Outstanding | 8,120,390 | 58,127,000 |
| Shares Change (YoY) | 0.41% | 10.9% |
| Float | 7,975,150 | 49,136,700 |
| Shares Held by Insiders | 1.79% | 11.6% |
Taxes
| Measure | Procyon | Industry median |
|---|---|---|
| Income Tax | $169.86K | $79.87K |
Scores
| Measure | Procyon | Industry median |
|---|---|---|
| Altman Z-Score | 1.88 | -0.22 |
| Piotroski F-Score | 4 | 4 |
Calculated by StockData from Procyon's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.